Figures computed from official regulatory filings — .
Ownershipinsiders 0.05% · institutions 4.98%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for CNBX Pharmaceuticals Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
CNBX Pharmaceuticals Inc., a clinical-stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the local treatment of lateral spreading, or sessile, colorectal polyps during colonoscopy, BRST-33 for the treatment of breast cancer, MLN-33 for the treatment of melanoma, and PRST-33 for the treatment of prostate cancer. In addition, it is developing RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
2 buys4 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Cannabics Inc. | Sell | $145.3K | SEC | ||
| MILLS THOMAS E |
| Sell |
| $205K |
| SEC |
| MILLS THOMAS Etrack record | Sell | $205K | SEC |
| MILLS THOMAS Etrack record | Buy | $200K | conv 70Unusual sizeFirst in 12mo | SEC |
| MILLS THOMAS Etrack record | Other | $200K | SEC |
| North American Mining Corp | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| HILFORD LOU | Sell | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MILLS THOMAS Etrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 47First in 12mo | SEC |